Dis-Chem Pharmacies (JSE:DCP) Current Deferred Revenue: R0 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JSE:DCP Dis-Chem Pharmacies Ltd JSE:DCP
86 GF Score
Price R30.00
GF Value R38.53
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Dis-Chem Pharmacies Current Deferred Revenue?

Dis-Chem Pharmacies JSE:DCP -0.33% 86 Current Deferred Revenue is R0 Mil as of Feb. 2026. GuruFocus rates JSE:DCP with a GF Score™ of 86/100 and a GF Value™ of R38.53 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Dis-Chem Pharmacies's current deferred revenue for the quarter that ended in Feb. 2026 was R0 Mil.

Dis-Chem Pharmacies Current Deferred Revenue Related Terms

Dis-Chem Pharmacies Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Dis-Chem Pharmacies's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dis-Chem Pharmacies Current Deferred Revenue Chart

Dis-Chem Pharmacies Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Dis-Chem Pharmacies Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
JSE:DCP
86GF Score
Dis-Chem Pharmacies Ltd JSE:DCP
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of R0 Mil mean?
Dis-Chem Pharmacies (JSE:DCP) has a Current Deferred Revenue of R0 Mil as of Feb. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Dis-Chem Pharmacies and its competitors.
Is Dis-Chem Pharmacies' Current Deferred Revenue too high?
Dis-Chem Pharmacies' current Current Deferred Revenue is R0 Mil. Overall, Dis-Chem Pharmacies has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' Current Deferred Revenue compare to competitors?
Dis-Chem Pharmacies' Current Deferred Revenue of R0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Dis-Chem Pharmacies and its competitors. Dis-Chem Pharmacies's current Current Deferred Revenue is R0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.53, compared to a current price of R30.00 — trading 22.1% below its estimated fair value. The current Current Deferred Revenue is R0 Mil. Dis-Chem Pharmacies' overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current Current Deferred Revenue is R0 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?

Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued. The current stock price of R30.00 is trading 22.1% below its estimated GF Value™ of R38.53. GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.

Key valuation signals for JSE:DCP:

  • Current Deferred Revenue: R0 Mil
  • GF Value™: R38.53 vs. price of R30.00 (22.1% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dis-Chem Pharmacies Business Description

Address 23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
86GF Score

Get the complete analysis for JSE:DCP

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R30.00
Price
R38.53
GF Value